Carole Patten Licensed Clinical is categorized under Medical Labs in Norman, OK and active since 2008.
Carole Patten Licensed Clinical was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Joseph Ripperger at the company’s single location by writing to 900 North Porter Avenue # 200, Norman, Oklahoma OK 73071 or by phoning (405) 579-4111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carole Patten Licensed Clinical |
| Contact Person: | Joseph Ripperger |
| Address: | 900 North Porter Avenue # 200, Norman, Oklahoma 73071 |
| Phone Number: | (405) 579-4111 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Carole Patten Licensed Clinical was started in 2008 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Ripperger for inquiries that concern Carole Patten Licensed Clinical by calling the company number (405) 579-4111, as your correspondence is most welcome. Additionally, the physical location of the single location of Carole Patten Licensed Clinical can be found at the coordinates 35.229745,-97.4413 as well as the street address 900 North Porter Avenue # 200 in Norman, Oklahoma 73071.
For its online presence, you may visit Carole Patten Licensed Clinical’s website at and engage with its social media outlets through on Twitter and on Facebook.